Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1997 | 12-1996 | 09-1996 | 06-1996 | 03-1996 | |
| Sales | 563,640 | 707,914 | 636,636 | 610,140 | 605,200 |
| Gross Profit | 563,640 | -191,226 | 636,636 | 610,140 | 605,200 |
| Operating Income | 563,640 | -1,441,296 | 636,636 | 610,140 | 605,200 |
| Other Income | 0 | 23,220 | 0 | 0 | 0 |
| Pre-tax Income | 563,640 | -1,418,076 | 636,636 | 610,140 | 605,200 |
| Net Income Continuous | 61,292 | 44,246 | 81,606 | 80,664 | 69,810 |
| Net Income | $61,292 | $77,550 | $81,606 | $80,664 | $69,810 |
| EPS Basic Total Ops | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Basic Continuous Ops | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Diluted Total Ops | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Diluted Continuous Ops | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EBITDA(a) | $563,640 | $707,914 | $636,636 | $610,140 | $605,200 |